Cibus (CBUS) Moat Score: 4/10 (As of Jun. 27, 2026)


CBUS Cibus Inc CBUS
53 GF Score
Price $1.36
GF Value $2.04
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Cibus Moat Score?

Cibus CBUS +1.49% 53 Moat Score is 4 as of Jun. 27, 2026. GuruFocus rates CBUS with a GF Score™ of 53/100 and a GF Value™ of $2.04 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,404 Biotechnology companies, Cibus ranks better than 88.82% on this metric.

Cibus has the Moat Score of 4, which implies that the company might have Narrow Moat - Discernible but modest moat.

Cibus has Narrow Moat: Cibus Inc has a discernible but modest moat due to its focus on innovation and R&D in agricultural biotechnology. While it holds valuable intellectual property, the company faces competition from larger players and lacks strong brand strength or significant customer switching costs.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Cibus might have Narrow Moat - Discernible but modest moat.

Cibus  (NAS:CBUS) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Cibus Moat Score Related Terms

CBUS vs OTLK, INO, RANI: Moat Score Comparison

For the Biotechnology subindustry, Cibus's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cibus Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cibus's Moat Score distribution charts can be found below:

* The bar in red indicates where Cibus's Moat Score falls into.


CBUS
53GF Score
Cibus Inc CBUS
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 4 mean?
Cibus (CBUS) has a Moat Score of 4 as of Jun. 27, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Cibus ranks #157 out of 1404 companies in the Biotechnology industry, placing it in the top 11.2%.
Is Cibus' Moat Score too high?
Cibus' current Moat Score is 4. The Biotechnology industry median Moat Score is 2.00. Cibus' value of 4 is 100% above this industry median. Based on the distribution chart, Cibus ranks #157 out of 1404 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Cibus has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cibus' Moat Score compare to OTLK and INO?
According to the Biotechnology industry distribution chart, Cibus ranks #157 out of 1404 companies for Moat Score. This places Cibus in the top 11% of its industry — outperforming the majority of peers. The industry median Moat Score is 2.00. Cibus' value of 4 is 100% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,404 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cibus's current Moat Score of 4 is 100% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cibus's current Moat Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cibus stock overvalued right now?
Based on GuruFocus' analysis, Cibus (CBUS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.04, compared to a current price of $1.36 — trading 33.3% below its estimated fair value. The current Moat Score is 4 and 100% above the Biotechnology industry median of 2.00. Cibus' overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Cibus (CBUS), the current Moat Score is 4 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cibus (CBUS) Overvalued in 2026?

Based on GuruFocus' analysis, Cibus stock appears to be undervalued. The current stock price of $1.36 is trading 33.3% below its estimated GF Value™ of $2.04. GuruFocus considers Cibus to be Possible Value Trap.

Key valuation signals for CBUS:

  • Moat Score: 4
  • GF Value™: $2.04 vs. price of $1.36 (33.3% below fair value)
  • GF Score™: 53/100 with 4 warning signs
  • Industry Position: 100% above the Biotechnology median (#157 of 1404)

No single metric tells the full story. See the CBUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cibus Business Description

Address 6455 Nancy Ridge Drive, San Diego, CA, USA, 92121
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
53GF Score

Get the complete analysis for CBUS

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.36
Price
$2.04
GF Value